Market Overview:
Chemotherapy-induced nausea and vomiting (CINV) is a severe and dreaded side effect that often occurs during cancer treatment. It affects a significant percentage, approximately 70% to 80%, of cancer patients. While antiemetic drugs are used to alleviate these symptoms, they may have limited success in reducing nausea, and the occurrence of nausea is typically more frequent than actual vomiting. CINV can manifest in various types, such as anticipatory, acute, delayed, breakthrough, and refractory, and its frequency and timing depend on the patient’s characteristics and the specific chemotherapeutic drugs used. The side effects of CINV can be debilitating, leading to weakness, weight loss, dehydration, anorexia, and reduced mental well-being.
Despite the availability of more potent antiemetic medications, emesis and nausea remain common side effects of chemotherapy. To improve patient outcomes, it is crucial to understand the mechanisms underlying CINV, identify high-risk individuals, and develop effective antiemetic therapies. Ongoing research in this field continues to be active.
Get Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/5823
Market Size:
The Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market is estimated to reach a value of US$ 3,071.1 million in 2023, with a projected CAGR of 5.7% during the forecast period (2023-2030).
Analysts have expressed concerns about the high cost of chemotherapy-induced nausea and vomiting treatment drugs, which could hinder the growth of the global market. For example, the average retail price of one capsule of Akynzeo (Netupitant and Palonosetron Capsules) is around US$ 570.8, as reported by GoodRx, Inc., a healthcare company tracking prescription drug prices in the U.S.
Market Drivers:
The rising prevalence of cancer globally is expected to increase the number of chemotherapies administered, driving the growth of the global cancer chemotherapy associated nausea and vomiting therapeutics market. Breast cancer and lung cancer are among the most common types of cancer, contributing to millions of cases globally. Additionally, cancer is a leading cause of death, accounting for nearly 10 million deaths in 2020.
Regional Insights:
North America is predicted to hold a dominant position in the global market due to increasing adoption of inorganic strategies such as distribution and supply agreements by key players in the region. For instance, in May 2022, Knight Therapeutics Inc. and Helsinn Healthcare SA entered into an exclusive license, distribution, and supply agreement for AKYNZEO and ALOXI products in several countries. The COVID-19 pandemic negatively impacted the global cancer chemotherapy associated nausea and vomiting therapeutics market, resulting in decreased hospital visits and cancer diagnosis rates.
Market Sementation:
The market is segmented based on type, drug class, route of administration, and distribution channel. Delayed CINV is expected to dominate the market due to increasing research and development efforts. Among drug classes, serotonin (5-HT3) receptor antagonists are projected to hold a significant market share due to the increasing launches of such drugs. The oral route of administration is likely to be the most dominant, as there is a rising trend in the launch of oral drugs to treat CINV. Hospital pharmacies are expected to be the leading distribution channel.
Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/5823
Key Market Trend:
The global cancer chemotherapy associated nausea and vomiting therapeutics market has seen key developments from various players, such as the launch of new medications and distribution agreements. For example, companies like Tetra Bio-Pharma Inc., Sandoz, Jupiter Wellness, Inc., and Camber Pharmaceuticals Inc. have introduced drugs for managing CINV.
Market Restraints:
The market is influenced by increasing government initiatives to establish cancer care centers, which aim to improve cancer treatment accessibility and quality. However, poor reimbursement policies and healthcare financing structures in certain regions may act as a restraint to market growth.
Top companies in Keyword Market:
Major players in the global market include Eisai Co., Ltd., Pharmanovia, Novartis AG, Merck & Co., Inc., Helsinn Healthcare SA, Dr. Reddy’s Laboratories Ltd., Validus Pharmaceuticals LLC, LGM Pharma, Astellas Pharma Inc., AdvaCare Pharma, Norgine, PV Pharma, Fresenius Kabi, Lupin, Hetero Healthcare Limited, Sino Biopharmaceutical Limited, Glenmark Pharmaceuticals Ltd., Otsuka Pharmaceutical Co., Ltd, OPKO Health, Inc., Weefsel Pharma, Pfizer Inc., Rosemont Pharmaceuticals Ltd., and Starton Therapeutics.
In conclusion, CINV remains a significant challenge for cancer patients undergoing chemotherapy. Efforts are being made to develop more effective antiemetic therapies and improve access to cancer care centers globally. The market for cancer chemotherapy associated nausea and vomiting therapeutics shows promise for continued growth, despite the challenges posed by the COVID-19 pandemic and reimbursement policies.
Avialable Discount Up To 25% Click Here: https://www.coherentmarketinsights.com/insight/request-discount/5823
Table of Contents: A Few Topics Discussed in the Report
For a comprehensive table of contents, readers are encouraged to speak with the analyst and fill out an inquiry form to access the detailed report.
Chapter 1: Setting the Research Framework (Research Objectives and Market Segmentation)
- In this initial chapter, we establish the research framework, outlining the research objectives and market segmentation to guide our investigation.
Chapter 2: Research Methodology
- This chapter delves into the comprehensive research methodology employed for the study. It encompasses both qualitative and quantitative research, highlighting primary and secondary data sources. The chapter also explores the process of market size estimation and data triangulation, ensuring the accuracy and reliability of our findings.
Chapter 3: Executive Summary
- An overview of the entire research report is presented in this chapter. The executive summary provides a concise yet comprehensive summary of the key insights and findings, allowing readers to grasp the essence of the study at a glance.
Chapter 4: Understanding Market Dynamics
- In this chapter, we delve into the global industry outlook and assess the market’s dynamics using Porter’s Five Forces Model. Additionally, the chapter addresses the impact of COVID-19 on the market and investigates the major strategies adopted by key players in the industry. Furthermore, we analyze the market positioning of key players to gain a deeper understanding of their roles in the market landscape.
Chapter 5: Global Market Analysis by Market Segmentation
- Here, we present key insights and forecasts related to the market segmentation. Through an in-depth analysis, we explore the market size and trends for each segment, providing valuable insights to stakeholders and decision-makers.
Chapter 6: Global Analysis by Geography
- This chapter focuses on key insights and market size forecasts for different geographical regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The diverse market dynamics in each region are thoroughly examined to identify potential opportunities and challenges.
Chapter 7: Analysis of the North American Market
- In this chapter, we provide a detailed analysis of the North American market, including key insights and market size forecasts, while also exploring the market segmentation within this region.
Chapter 8: Analysis of the European Market
- Similarly, this chapter offers an in-depth analysis of the European market, encompassing key insights and market size forecasts for the identified market segments within the region.
Chapter 9: Analysis of the Asia Pacific Market
- The Asia Pacific market is thoroughly analyzed in this chapter, presenting key insights and market size forecasts for the various market segments within the region.
Chapter 10: Analysis of the Latin American Market
- This chapter focuses on providing a comprehensive analysis of the Latin American market, presenting key insights and market size forecasts for the identified market segments within this region.
Chapter 11: Analysis of the Middle East & Africa Market
- In this chapter, we conduct a detailed analysis of the Middle East & Africa market, offering key insights and market size forecasts for the various market segments within this region.
Chapter 12: Company Profiles
- The final chapter comprises profiles of the companies involved in the industry. Each profile includes essential information such as company basic information, manufacturing base, sales area, company sales, net income highlights, and a comprehensive business overview. Furthermore, notable company news is also included to provide readers with a holistic understanding of each company’s operations and achievements.
Why Choose Coherent Market Insights?
Discover the cutting-edge solution from Coherent Market Insights: a business intelligence-powered dynamic storytelling platform tailored to your specific market needs. With a comprehensive analysis of emerging trends and trusted insights across 20,000+ rapidly growing and specialized sectors, we empower you to make critical decisions that drive substantial revenue growth and secure your future prosperity. Our expertise extends to delivering a profound understanding of the global competitive landscape, encompassing your region, country, sector, and key industry players. Streamline your operations and optimize resources with our integrated presentation tool, saving up to 70% of your time and efforts in crafting investor pitches, sales & marketing strategies, R&D initiatives, and product development proposals. Gain access to more than 15 essential market indicators relevant to your market, all packaged in user-friendly Excel and Interactive PDF formats for seamless data distribution.
Contact Us:
Mr. Shah
US: +12067016702 / UK: +4402081234027
Coherent Market Insights Pvt Ltd, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Choose Coherent Market Insights for unparalleled market analysis and strategic decision-making.